Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October 19-23, 2024. We invite you to visit us and explore how our innovative CRO services in clinical trials and nuclear medicine can support your research and development efforts.
Our team will be available throughout the event to discuss cutting-edge solutions in medical imaging and radiopharmaceutical development. Whether you’re interested in exploring partnership opportunities, developing nuclear medicine procedures or learning about our latest projects, we look forward to connecting with you.
See you in Hamburg!
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant